上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Voacangine 纯度: 98.78%
Voacangine是 TRPV1 和 TRPM8 的拮抗剂,但也是 TRPA1 的激动剂 (EC50=8 μM)。Voacangine 竞争性抑制薄荷醇与 TRPM8 的结合(IC50=9 μM),对 icilin 表现出非竞争性抑制 (IC50=7 μM)。Voacangine 选择性地消除化学激动剂诱导的 TRPM8 激活,而不影响冷诱导的激活。Voacangine 是从美洲山梨 Voacanga africana 的根皮中分离得到的生物碱。
Voacangine Chemical Structure
CAS No. : 510-22-5
| 规格 | 价格 | 是否有货 | 数量 |
|---|---|---|---|
| 1 mg | ¥2800 | In-stock | |
| 5 mg | ¥9800 | In-stock | |
| 10 mg | 询价 | ||
| 50 mg | 询价 |
* Please select Quantity before adding items.
| 生物活性 |
Voacangine is an antagonist for TRPV1 and TRPM8 but as an agonist for TRPA1 (EC50=8 μM). Voacangine competitively blockes capsaicin binding to TRPV1 (IC50=50 μM). Voacangine competitively inhibits the binding of menthol to TRPM8 (IC50=9 μM) and it shows noncompetitive inhibition against icilin (IC50=7 μM). Voacangine selectively abrogates chemical agonist-induced TRPM8 activation and did not affect cold-induced activation. Voacangine is an alkaloid isolated from the root bark of Voacanga africana[1]. |
IC50 & Target |
EC50: 8 μM (TRPA1)[1]. |
|---|---|
| 体外研究 (In Vitro) |
Voacangine (100 μM; HEK cells) triggeres Ca2+ influx on TRPA1-expressing cells but not on the other TRPs. Voacangine not only suppresses capsaicin (CAP)-induced TRPV1 activation but also suppressed menthol- and icilin-induced TRPM8 activation. Voacangine attenuates CAP-induced TRPV1 activation. Voacangine shows a dose-dependent suppression of response by CAP. Voacangine competitively inhibits CAP on TRPV1. Voacangine is a competitive antagonist and that Voacangine and CAP act at the same recognition site on hTRPV1. Voacangine is an antagonist for TRPV1 and TRPM8 but an agonist for TRPA1. Voacangine selectively blocks CAP- and heat-induced activation of TRPV1. Voacangine is the first naturally occurring TRPM8 antagonist that competes with Menthol. Voacangine selectively blocks chemical agonist induced activation of TRPM8. Voacangine acts as an agonist for TRPA1[1]. Voacangine inhibits the proliferation of HUVECs at an IC50 of 18 μM with no cytotoxic effects. Voacangine decreases the expression levels of hypoxia inducible factor-1α and its target gene, VEGF, in a dose-dependent manner[2]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
| 体内研究 (In Vivo) |
Voacangine significantly suppresses in vitro angiogenesis, such as VEGF-induced tube formation and chemoinvasion[2]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
| 分子量 |
368.47 |
| Formula |
C22H28N2O3 |
| CAS 号 |
510-22-5 |
| 性状 |
固体 |
| 颜色 |
White to off-white |
| 结构分类 |
|
| 初始来源 |
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| 纯度 & 产品资料 |
纯度: 98.78%
Data Sheet (542 KB) SDS (393 KB)
COA (270 KB) HNMR (227 KB) LCMS (79 KB) 产品使用指南 (1538 KB) |
| 参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务